Latest News and Press Releases

中国上海, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Everest Medicines，一家专注于创新药的开发及商业化以满足中国（含香港特别行政区、澳门特别行政区以及台湾地区）及其他亚洲市场患者尚未满足的医疗需求的生物制药公司，今日宣布在中国进行Nefecon临床试验的申请已获中国国家药品监督管理局批准。Nefecon是Everest...

SHANGHAI, China, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address...

SHANGHAI, China and SAN FRANCISCO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the...

- Primary Endpoint of Statistical Superiority Related to Deep Response (VGPR or Better) Was Not Met; However, Zanubrutinib Demonstrated More Frequent VGPRs (28.4% vs.19.2% in Overall Population)-...

SHANGHAI, China, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer in China’s premium electric vehicle market, today announced that it will hold its 2019...

SHANGHAI, China, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Baozun Inc. (Nasdaq: BZUN) (“Baozun” or the “Company”), the leading brand e-commerce service partner that helps brands execute their e-commerce...

CAMBRIDGE, Mass. and BEIJING, China, Dec. 13, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...

SHANGHAI, China, Dec. 11, 2019 (GLOBE NEWSWIRE) -- 360 Finance, Inc. (NASDAQ: QFIN) (“360 Finance” or the “Company”), a leading digital consumer finance platform, today announced that it was...

SHANGHAI, China, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Huazhu Group Limited (NASDAQ: HTHT) (the “Company”), a leading and fast-growing hotel group, today announced that its 2019 annual general meeting...

SHANGHAI, China, Dec. 09, 2019 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS” or the “Company”) (Nasdaq: GDS) today announced that the underwriters of its previously announced public offering have...